We are live on ! Find out more
SAM

Simplify Asset Management Portfolio holdings

AUM $7.19B
1-Year Est. Return 6.88%
This Fund
S&P 500
This Quarter Est. Return
+0.82%
1 Year Est. Return
+6.88%
3 Year Est. Return
+44.98%
5 Year Est. Return
+50.08%
10 Year Est. Return
AUM
$6.13B
AUM Growth
+$696M
Cap. Flow
+$703M
Cap. Flow %
11.47%
Top 10 Hldgs %
92.45%
Holding
166
New
37
Increased
75
Reduced
18
Closed
24

Sector Composition

Rank Sector Weight
1 Healthcare 5.76%
2 Energy 0.41%
3 Industrials 0.31%
4 Technology 0.2%
5 Real Estate 0.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EA
126
DELISTED
Electronic Arts
EA
$265K ﹤0.01%
1,296
+301
+30% +$60.8K
AMAT icon
127
Applied Materials
AMAT
$428B
$258K ﹤0.01%
+1,005
New +$241K
LRCX icon
128
Lam Research
LRCX
$390B
$253K ﹤0.01%
+1,478
New +$230K
QNRX
129
Quoin Pharmaceuticals
QNRX
$9.62M
$252K ﹤0.01%
+17,448
New +$238K
TTWO icon
130
Take-Two Interactive
TTWO
$46.1B
$248K ﹤0.01%
+969
New +$242K
PM icon
131
Philip Morris
PM
$295B
$243K ﹤0.01%
1,516
+206
+16% +$31.9K
NTRA icon
132
Natera
NTRA
$46.4B
$238K ﹤0.01%
+1,041
New +$217K
ROK icon
133
Rockwell Automation
ROK
$49B
$229K ﹤0.01%
+588
New +$221K
RDDT icon
134
Reddit
RDDT
$31.1B
$226K ﹤0.01%
+982
New +$207K
TEAM icon
135
Atlassian
TEAM
$37.8B
$219K ﹤0.01%
+1,351
New +$212K
FICO icon
136
Fair Isaac
FICO
$22.5B
$203K ﹤0.01%
+120
New +$207K
QVCGA
137
DELISTED
QVC Group Inc Series A
QVCGA
$175K ﹤0.01%
16,696
+4,696
+39% +$51.1K
KLRS
138
Kalaris Therapeutics
KLRS
$96.8M
$169K ﹤0.01%
+20,074
New +$128K
AGL icon
139
Agilon Health
AGL
$1.6B
$151K ﹤0.01%
8,752
+4,193
+92% +$81.3K
AUR icon
140
Aurora
AUR
$13.8B
$42.1K ﹤0.01%
+10,969
New +$50.2K
IRWD icon
141
Ironwood Pharmaceuticals
IRWD
$714M
$36.9K ﹤0.01%
+10,946
New +$28.4K
FUBO icon
142
FuboTV Inc
FUBO
$273M
$31.8K ﹤0.01%
+1,050
New +$41.9K
ADBE icon
143
Adobe
ADBE
$105B
-1,717
Closed -$606K
AKRO
144
DELISTED
Akero Therapeutics
AKRO
-145,609
Closed -$6.91M
APLT
145
DELISTED
Applied Therapeutics
APLT
-4,487,505
Closed -$2.71M
ARQT icon
146
Arcutis Biotherapeutics
ARQT
$3.18B
-317,997
Closed -$5.99M
BRK.B icon
147
Berkshire Hathaway Class B
BRK.B
$1.13T
-2,064
Closed -$1.04M
CAH icon
148
Cardinal Health
CAH
$55.4B
-12,223
Closed -$1.91M
COR icon
149
Cencora
COR
$61.2B
-7,406
Closed -$2.31M
EYE icon
150
National Vision
EYE
$1.81B
-197,840
Closed -$5.77M

Similar funds

Simplify Asset Management's Q4 2025 Portfolio in Review

As of Q4 2025, Simplify Asset Management held 166 positions worth $6.13B, up 13% from $5.43B the previous quarter. Its ten largest holdings account for 92% of the portfolio.

Simplify Asset Management deployed $703M of net new capital in Q4 2025, opening 37 new positions and adding to 75 existing holdings. Its largest new stake was Amgen: 52,350 shares worth $17.1M.

By sector, the portfolio is most concentrated in Healthcare at 5.8% of assets, up from 3.3% a quarter earlier, followed by Energy and Industrials.

On the sell side, the largest reduction was Simplify Aggregate Bond ETF, an estimated $38.7M trimmed.

  • Simplify Asset Management's largest Q4 2025 buy was Amgen: 52,350 shares worth $17.1M.
  • Simplify Asset Management added most to Simplify Government Money Market ETF in Q4 2025, an estimated $1.05B increase.
  • Simplify Asset Management's biggest Q4 2025 reduction was Simplify Aggregate Bond ETF, cutting an estimated $38.7M.
  • Simplify Asset Management fully exited Simplify Currency Strategy ETF in Q4 2025, selling an estimated $9.3M.
  • Simplify Asset Management's ten largest holdings make up 92% of its $6.13B portfolio in Q4 2025.
  • Simplify Asset Management opened 37 new positions and closed 24 in Q4 2025.
  • Simplify Asset Management's portfolio value rose 13% quarter-over-quarter to $6.13B.

Based on Simplify Asset Management's 13F filing for Q4 2025, filed 9 Feb 2026.